Adherium Ltd
Adherium Limited is a digital health company.
The business
Adherium Limited is a digital health company. The Company provides integrated digital health solutions and connected respiratory medical devices. The Company’s Hailie platform solution provides clinicians, healthcare providers and patients access to remotely monitor medication usage parameters and adherence, supporting reimbursement for qualifying patient management. The Hailie solution includes a suite of integration tools to enable the capture and sharing of health data through mobile and desktop apps, software development kit and application programming interface (API) integration tools, and the Company’s own broad range of sensors connected to respiratory medications. The Company’s Hailie solution is designed to provide visibility to healthcare providers of medication use history to better understand patterns in patient respiratory disease. Its Hailie Smartinhaler sensor technology and cloud-based data platform provides real-time feedback on patients' use of inhaled medication.
Share price
Market Statistics
Valuation
Trading Activity
Performance
Latest news
Market wrap: Australian market follows Wall Street down
Once again, an Australian encore followed a Wall Street sell-off as investors grew increasingly nervous about the prospect for rate falls, with bond yields rising and shares in interest rate sensitive areas falling. Weakness in commodity prices didn’t help the Australian market, with falling prices for iron ore and gold helping to broaden the decline […]
Adherium partners with AstraZeneca for Hailie Smartinhaler clinical trial
Digital health solutions specialist Adherium (ASX: ADR) is celebrating news that global biopharmaceutical giant AstraZeneca has selected its Hailie Smartinhaler platform for a clinical trial. Under the contract, valued at $1.1 million, AstraZeneca will use the devices to record and transfer medication usage data over a period of three years. Adherium will provide Hailie Smartinhalers, […]
Adherium’s Hailie Smartinhaler receives FDA approval for use with leading AstraZeneca devices
Medical device developer Adherium (ASX: ADR) has been given clearance by the US Food and Drug Administration (FDA) for its Hailie Smartinhaler to be used with AstraZeneca’s Airsupra and Breztri inhalation devices. Airsupra is the first FDA-approved rescue medication for asthma patients and Breztri is a triple combination for patients with chronic obstructive pulmonary disorder […]
Adherium joins forces with US health group to offer remote medical management for high-risk respiratory patients
New Zealand-based Adherium (ASX: ADR) is set to form a collaborative alliance with US-based HGE Health to remotely evaluate, treat and manage patients with severe asthma and chronic obstructive pulmonary disease. The respiratory device manufacturer will integrate its own sensor and software technology into HGE Health’s established telemedicine platform to provide better overall health care […]
Looking for charts & signals? See the tab.
Unlock the full research library - free.
Create a free account to access every broker report, CEO interview, IPO alert, and daily market wrap. No credit card. No paywall.